针对性早期息护理 (STEP) 的症状查与晚期癌症患者的通常护理:一种混合方法研究
Camilla Zimmermann1,2,3,4,5, Ashley Pope6, Breffni Hannon6,7,8
1Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada. camilla.zimmermann@uhn.ca.
概括
早期的息治疗改善了晚期癌症患者的治疗结果. 针对性早期息护理 (STEP) 的症状查显示了初步的益处和患者接受,为未来的试验铺平了道路.
科学领域:
- 在瘤学瘤学.
- 抚慰性护理是一种缓解性护理.
- 临床试验 临床试验
背景情况:
- 建议早期整合息护理,但往往受到资源的限制.
- 资源限制阻碍了早期息护理服务的常规实施.
- 这项研究解决了有效的早期息护理提供模式的需求.
研究的目的:
- 评估一项混合方法研究的初步发现,该研究涉及针对性早期息护理 (STEP) 的症状查.
- 评估STEP干预在晚期实体瘤患者中的可行性和初步疗效.
- 探索患者在症状查和早期息治疗转诊方面的经验.
主要方法:
- 一项随机对照试验 (RCT) 将STEP与高级固体瘤患者 (预后6-36个月) 的单独症状查进行比较.
- 步骤涉及定期的症状查与自动化息护理护士通知中度至重度症状.
- 收集了患者报告的结果 (生活质量,抑郁症,症状控制,满意度) 和定性访谈.
主要成果:
- 由于COVID-19大流行,该试验被提前停止,69名参与者被随机选择.
- 在STEP手臂中,显著更高的比例的患者接受了息治疗 (45%对17%,p=0.009).
- 初步结果有利于STEP,定性数据表明患者接受和查和转诊过程的感知益处.
结论:
- 尽管试验的动力不足,但试验显示了STEP的初步有利结果.
- 定性发现证实了STEP干预在患者中的可接受性.
- 结果将为未来一个更大的RCT提供信息,该RCT将面对面和虚拟 STEP 交付结合起来.
相关概念视频
Continuing Care
1.5K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Preventive Healthcare Services
1.1K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.1K
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K


